Literature DB >> 11693192

Endocardial expression and functional characterization of endothelin-1.

O Saetrum Opgaard1, M Adner, T H Peters, C B Xu, L Stavenow, S Gulbenkian, D Erlinge, L Edvinsson, H S Sharma.   

Abstract

Endothelin-1 (ET-1), a 21 amino acid peptide exerts a wide range of biological activities including vasoconstriction, mitogenesis and inotropic effects on the heart. In this study, we examined whether endocardial endothelial cells express ET-1 and evaluated its functional properties. Using immunofluorescence localization method, we demonstrated cytoplasmic staining of ET-1 in the human endocardial endothelial cells from the right atrium and left ventricle. Employing reverse transcriptase polymerase chain reaction (RT-PCR) expression of ET-1 mRNA and its receptors ET(A) and ET(B) mRNAs were found in human myocardial as well as in endocardial endothelial cells. Biological activity of endocardial endothelial cells derived ET-1 was established as the conditioned media obtained from cultured porcine endocardial endothelial cells induced a slowly developing, strong and long-lasting contraction of circular rat aortic segments, with similar characteristics to that obtained with exogenous ET-1. Furthermore, the selective endothelin-A receptor antagonist, FR 139317, blocked the conditioned media induced contractions. Our results suggest that endocardial endothelial cells express and release biologically active ET-1 which could play a pivotal role in the regulation of myocardial contractility as well as a circulatory peptide may further act in other peripheral target organs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11693192     DOI: 10.1023/a:1011952504093

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  Factors released from endocardium of the ferret and pig modulate myocardial contraction.

Authors:  J A Smith; A M Shah; M J Lewis
Journal:  J Physiol       Date:  1991-08       Impact factor: 5.182

2.  Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: identity of human and porcine endothelin.

Authors:  Y Itoh; M Yanagisawa; S Ohkubo; C Kimura; T Kosaka; A Inoue; N Ishida; Y Mitsui; H Onda; M Fujino
Journal:  FEBS Lett       Date:  1988-04-25       Impact factor: 4.124

3.  The human endothelin-B receptor gene. Structural organization and chromosomal assignment.

Authors:  H Arai; K Nakao; K Takaya; K Hosoda; Y Ogawa; S Nakanishi; H Imura
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

4.  Functional and autoradiographic evidence for endothelin 1 receptors on human and rat cardiac myocytes. Comparison with single smooth muscle cells.

Authors:  C J Moody; M R Dashwood; R M Sykes; M Chester; S M Jones; M H Yacoub; S E Harding
Journal:  Circ Res       Date:  1990-09       Impact factor: 17.367

5.  The visualisation of cardiovascular innervation in the guinea pig using an antiserum to protein gene product 9.5 (PGP 9.5).

Authors:  S Gulbenkian; J Wharton; J M Polak
Journal:  J Auton Nerv Syst       Date:  1987-03

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.

Authors:  K Sogabe; H Nirei; M Shoubo; A Nomoto; S Ao; Y Notsu; T Ono
Journal:  J Pharmacol Exp Ther       Date:  1993-03       Impact factor: 4.030

8.  Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle.

Authors:  G O'Reilly; D S Charnock-Jones; A P Davenport; I T Cameron; S K Smith
Journal:  J Clin Endocrinol Metab       Date:  1992-12       Impact factor: 5.958

9.  Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia.

Authors:  T Tønnessen; A Giaid; D Saleh; P A Naess; M Yanagisawa; G Christensen
Journal:  Circ Res       Date:  1995-05       Impact factor: 17.367

10.  Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats.

Authors:  T Watanabe; Y Awane; S Ikeda; S Fujiwara; K Kubo; T Kikuchi; K Kusumoto; M Wakimasu; M Fujino
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

View more
  4 in total

1.  Heart ischaemia-reperfusion induces local up-regulation of vasoconstrictor endothelin ETB receptors in rat coronary arteries downstream of occlusion.

Authors:  G F Skovsted; L S Kruse; R Larsen; A F Pedersen; S Trautner; M Sheykhzade; L Edvinsson
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

2.  Myocardial ischemia-reperfusion enhances transcriptional expression of endothelin-1 and vasoconstrictor ETB receptors via the protein kinase MEK-ERK1/2 signaling pathway in rat.

Authors:  Gry Freja Skovsted; Lars Schack Kruse; Lukas Adrian Berchtold; Anne-Sofie Grell; Karin Warfvinge; Lars Edvinsson
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

3.  Endothelin-1 and norepinephrine overflow from cardiac sympathetic nerve endings in myocardial ischemia.

Authors:  Masashi Tawa; Satoshi Yamamoto; Mamoru Ohkita; Yasuo Matsumura
Journal:  Cardiol Res Pract       Date:  2012-06-25       Impact factor: 1.866

4.  Structural heart defects associated with ETB mutation, a cause of Hirschsprung disease.

Authors:  Ko-Chin Chen; Ko-Chien Chen; Zan-Min Song; Geoffrey D Croaker
Journal:  BMC Cardiovasc Disord       Date:  2021-10-02       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.